BROADWOOD CAPITAL INC - Q2 2023 holdings

$1.34 Billion is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
MNST  MONSTER BEVERAGE CORP NEW$534,937,341
+6.4%
9,312,9760.0%39.99%
+13.0%
STAA  STAAR SURGICAL CO$461,726,621
-17.8%
8,783,0820.0%34.52%
-12.7%
AXON  AXON ENTERPRISE INC$148,303,297
-13.2%
760,0620.0%11.09%
-7.8%
IWM  ISHARES TRrussell 2000 etf$129,216,300
+5.0%
690,0000.0%9.66%
+11.5%
LCTX  LINEAGE CELL THERAPEUTICS IN$49,259,034
-6.0%
34,935,4850.0%3.68%
-0.1%
AGE  AGEX THERAPEUTICS INC$2,677,060
+34.7%
2,997,1560.0%0.20%
+42.9%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO42Q3 202359.1%
MONSTER BEVERAGE CORP NEW34Q3 202349.7%
ISHARES TR33Q3 202314.8%
ONCOCYTE CORPORATION31Q2 20234.6%
BIOTIME INC25Q2 201917.8%
AXON ENTERPRISE INC24Q3 202313.4%
AGEX THERAPEUTICS INC20Q3 20231.5%
LINEAGE CELL THERAPEUTICS INC17Q3 20235.1%
ASTERIAS BIOTHERAPEUTICS INC16Q4 20182.9%
CYNOSURE INC15Q4 201610.4%

View BROADWOOD CAPITAL INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
42024-05-13
42024-04-15
13F-HR2024-02-14
42024-02-08
42024-01-10
42024-01-05
42023-11-30
13F-HR2023-11-14
42023-11-14

View BROADWOOD CAPITAL INC's complete filings history.

Compare quarters

Export BROADWOOD CAPITAL INC's holdings